Skip to main content
. 2020 Nov 2;8(4):640. doi: 10.3390/vaccines8040640
CVID common variable immune deficiency
GMR geometric mean rate
GMT geometric mean antibody titers
HA hemagglutinin
HI hemagglutination inhibition assay
IVIG Intravenous immunoglobulin
PID primary immune deficiency
QIV qudrivalent inactivated vaccine
aQIV adjuvant qudrivalent inactivated vaccine
TIV trivalent inactivated vaccine
aTIV adjuvant trivalent inactivated vaccine